Skip to main content
. 2018 Jun 21;2018(6):CD007105. doi: 10.1002/14651858.CD007105.pub4

Strazisar 2012.

Methods Double‐blinded (participant/outcome assessor), randomized clinical trial
Sequence generation by a computer‐based, random numbers generator
Follow‐up: 3 months
Participants Participants: 60 women in a hospital setting in Ljubljana, Slovenia
Operation: breast cancer surgery with axillary lymphadenectomy
Groups, size: 30/30
Age (all, 1, 2): 60 (30‐84), 57.4, 62.9
All female participants
Comorbidities: diabetes, groups 1, 2 (4, 8); depression, groups 1, 2 (1, 4)
Remarks: ASA I, II, and III
Interventions Group 1 (levobupivacaine): intra‐op: before wound closure, a fenestrated wound catheter was placed near the axillary vein and upon the whole length over the upper side of the wound. The wound catheter was fenestrated along 15 cm in the distal part. A bolus of 15 mL of 0.25% levobupivacaine was injected into the wound through the catheter immediately after wound closure. Surgical drains and the fenestrated catheter were clamped for 5 min to enable bolus absorption. Elastomeric pump was connected containing 100 mL of 0.25% levobupivacaine. Infusion at 2 mL/h was continuous for 50 h
Group 2 (piritramide): intra‐op: continuous IV infusion with piritramide (30 mg), metoclopramide (20 mg) and metamizole (2.5 g) in 100 mL of 0.9% sodium chloride (3 mL/h to 6 mL/h) until 24 h postoperatively
Adjuvants: none
Immediate post‐op pain control: significantly improved, significantly reduced analgesic consumption
Outcomes Continuous: none
Dichotomus: overall pain/no pain at 3 months
Other reported: nausea, opioid consumption, and length of hospital stay and were measured
Adverse events: 3 participants (2, 1) underwent additional surgical procedures due to haematoma and 9 participants (5, 4) experienced inflammation postoperatively
Notes Funding sources: no funding source given
Conflicts of interest: "no potential conflicts of interest were disclosed."
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomization was performed using random numbers generated by a computer
Allocation concealment (selection bias) Low risk Quote: "randomization and numbers were placed in sealed opaque envelopes to ensure concealment of allocation at enrollment."
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "participants were randomly grouped."
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: "clinicians who recorded data about chronic pain were blinded about randomisation group of patients."
Incomplete outcome data (attrition bias) 
 All outcomes Low risk All participants completed the follow‐up evaluation.
Selective reporting (reporting bias) Low risk No subgroup analysis or selective reporting was noted.
Null bias Low risk Quote: "pain (at 3 months) was reported by 17% and 50% of patients." Continuous infusion of local anesthetic reduced pain compared to control.